FOUR max pain, gamma exposure (GEX) & options open interest
As of close · rank #746 by open interest · snapshot page
FOUR's nearest-expiration max pain is 40.00 for 2026-11-20, net GEX is 391,529, its put/call open-interest ratio is 0.46. These are whole-chain derived aggregates as of Oct 23, 2026 close.
FOUR max pain and GEX snapshot
End-of-day snapshot for . Nearest-expiration max pain uses the expiry shown on its card; GEX uses the whole chain. Missing values are unavailable, not zero.
Prices are in US dollars per share. Net GEX is modeled dollar-delta change per $1 underlying move. Max pain minimizes aggregate intrinsic payout for that expiration; it is not a closing-price forecast. Signed GEX uses calls positive and puts negative, a model convention rather than observed dealer inventory. The flip is a confirmed zero crossing; walls locate side-specific concentrations, not guaranteed support or resistance.
Learn how to read the max pain payout example, GEX chart, gamma flip and walls, and open interest versus trading volume.
Advanced options analysis
Public aggregate analysis from the dated chain, normalized where possible for comparison across tickers. Catalyst intensity measures unusual pricing and activity; it does not identify an event, predict direction, or establish that an investment is attractive.
FOUR closed 36.8% below its gamma max of 53.09. It is 3.7% above the delta neutral price of 37.37. Total open interest is 77,978, +0.1% versus the previous session. What gamma max means · What delta neutral means
History
Hover for valuesDrag to panScroll to zoomClick a series to hide it ← → step a session+ − zoomTouch: swipe to pan, pinch to zoom, hold for the crosshair
Analysis visualizations
Daily ticker aggregates through 2026-10-23. The max pain curve pools all listed expirations; individual contracts are outside the public dataset.
No matching visualizations.
Aggregate IV history
Chart loads when this section is in view.
Swipe chart sideways to see the full range.
In today's screens
Neighbours by open interest
Cite or embed this snapshot
Cite this canonical page or embed the live levels widget. All of them carry public derived aggregates, not contract-level quotes. Credited citations and unmodified embeds need no permission; see the terms.
Canonical source: https://halfonadouble.com/stock/FOUR
Questions people ask about FOUR
What is FOUR's max pain for the nearest expiration?
As of Oct 23, 2026 close, nearest-expiration max pain is 40.00 for the 2026-11-20 expiration. It is a payout-minimizing strike for one expiration. An all-expiration pooled value is a different comparison, and neither establishes where the underlying will close. Max pain definition and worked payout example.
Our 2025 max-pain study compares historical Thursday levels with Friday underlying closes and an unchanged-price baseline. Its scope and results are separate from this current ticker snapshot.
What do FOUR's gamma exposure and gamma flip show?
Signed net GEX is 391,529 as of Oct 23, 2026 close. No confirmed GEX flip is available; this does not imply a zero exposure level. These aggregate model outputs use calls positive and puts negative. Their sign does not identify dealers' actual positions or predict the next move. How to interpret GEX, gamma flip and walls.
Where is FOUR's gamma max today?
As of Oct 23, 2026, the gamma max for FOUR is 53.09, +36.8% from the 38.80 close. Gamma max is the underlying price at which the summed gamma of every open contract is largest; how it is computed and why it matters.
Is FOUR above or below its delta neutral price?
FOUR closed above delta neutral: 38.80 against a delta neutral price of 37.37. The delta neutral price is where the summed delta of the whole chain is zero; the definition.
How much open interest does FOUR have?
77,978 contracts of open interest across 179 listed contracts on Oct 23, 2026, +0.1% versus the previous session. What open interest measures.
Levels are recomputed after every trading day from licensed end-of-day options data; only derived aggregates are published. Methodology · Data and licence · Not investment advice.